|
|
Volumn 100, Issue 17, 2008, Pages 1196-1199
|
|
Leaders worry that U.S. is losing edge on cancer clinical trials
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
LAPATINIB;
TRASTUZUMAB;
BRAIN CANCER;
BREAST CANCER;
CANCER RESEARCH;
CLINICAL TRIAL;
COST;
DRUG INDUSTRY;
HEALTH CARE;
HUMAN;
LEADERSHIP;
MEDICAL RESEARCH;
MEDICAL SOCIETY;
MELANOMA;
NOTE;
ONCOLOGY;
POPULATION;
PRIORITY JOURNAL;
PUBLIC HEALTH;
SARCOMA;
UNITED STATES;
CLINICAL TRIALS AS TOPIC;
COOPERATIVE BEHAVIOR;
DRUG INDUSTRY;
EUROPE;
GOVERNMENT REGULATION;
HUMANS;
INTERNATIONAL COOPERATION;
NATIONAL CANCER INSTITUTE (U.S.);
NEOPLASMS;
RESEARCH DESIGN;
RESEARCH SUPPORT AS TOPIC;
UNITED STATES;
|
|
EID: 51749102468
PISSN: 00278874
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djn318 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|